WHO list of SARS-CoV-2 IVDs currently under assessment for Emergency Use Listing updated
IVD
First paediatric linezolid prequalified
M
WHO Prequalification Unit (PQT) added the below new product to its prequalified list:
Independent Performance Evaluation for SARS-COV-2 Antigen RDTS
IVD
WHO PQT in collaboration with PATH and FIND will perform an independent performance evaluation to generate additional performance data for RDTs that are undergoing EUL assessment and for those that
Macleods’ Pyrimethamine/Sulfadoxine + Amodiaquine (hydrochloride) dispersible tablets prequalified
M
WHO Prequalification Unit (PQT) added the below new product to its prequalified list: